ZYTORVI Dr Reddys Laboratories Australia Pty Ltd
Product name
ZYTORVI
Accepted date
Jun-2026
Active ingredients
toripalimab
Summary of proposed indication
ZYTORVI (toripalimab), used with platinum-based chemotherapy, is proposed as an initial treatment for adults with nonsquamous non-small cell lung cancer. ZYTORVI is for cancer that cannot be removed by surgery, has spread locally or to other parts of the body, and does not have changes in the EGFR or ALK genes.
Application type
C (new indication)
Publication date
Jun-2026